PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer.

Journal: Applied clinical informatics
Published Date: Jan 19, 2022

Abstract

BACKGROUND AND OBJECTIVE: Prostate cancer (PCa) is a severe public health issue and the most common cancer worldwide in men. Early diagnosis can lead to early treatment and long-term survival. The addition of the multiparametric magnetic resonance imaging in combination with ultrasound (mpMRI-U/S fusion) biopsy to the existing diagnostic tools improved prostate cancer detection. Use of both tools gradually increases in every day urological practice. Furthermore, advances in the area of information technology and artificial intelligence have led to the development of software platforms able to support clinical diagnosis and decision-making using patient data from personalized medicine.

Authors

  • Ioannis Tamposis
    Department of Computer Science and Biomedical Informatics, University of Thessaly, Lamia, Greece.
  • Ioannis Tsougos
    Department of Medical Physics, Medical School, University of Thessaly, Larisa, Greece.
  • Anastasios Karatzas
    Department of Urology, Medical School, University of Thessaly, Larisa, Greece.
  • Katerina Vassiou
    Radiology and Anatomy Department, Medical School, University of Thessaly, Larisa, Greece.
  • Marianna Vlychou
    Radiology Department, Medical School, University of Thessaly, Larisa, Greece.
  • Vasileios Tzortzis
    Department of Urology, Medical School, University of Thessaly, Larisa, Greece.

Keywords

External Resources

Popular Topics
Recent Journals